However, patients with FOP are at no greater risk of DMGs (or any other cancers), indicating that ACVR1 mutations alone are not sufficient for tumorigenesis [146,147,151,155]. This evidence concerns the gene ACVR1 and fibrodysplasia ossificans progressiva.